Related Experiment Video
Updated: Jun 12, 2026

Correlating Gene-specific DNA Methylation Changes with Expression and Transcriptional Activity of Astrocytic KCNJ10 (Kir4.1)
Published on: September 26, 2015
Downregulation of WIF-1 by hypermethylation in astrocytomas
Zhuanyi Yang1, Ying Wang, Jiasheng Fang
1Department of Neurosurgery, Xiangya Hospital of Central South University, Changsha, China.
Abstract:
Wnt inhibitory factor-1 (WIF-1) acts as a Wnt antagonist and tumor suppressor, but hypermethylation of WIF-1 gene promoter and low expression of WIF-1 activate Wnt signaling aberrantly and induce the development of several human tumors. By using RT-PCR, immunohistochemistry and methylation-specific PCR, we analyzed the expression and methylation of WIF-1 in 4 normal brain tissues, 35 freshly resected astrocytoma tissues and 4 glioblastoma-derived cell lines. Significant downregulation of WIF-1 mRNA and protein expression levels was observed in astrocytoma tissues compared with normal brain tissues. Significant association between WIF-1 downregulation and pathological grade of astrocytomas was found. WIF-1 gene aberrant methylation was observed in 19 of 35 (54.29%) tumor samples. The promoter methylation tumors showed low WIF-1 protein and mRNA expression, whereas the promoter unmethylation tumors displayed high protein and mRNA expression levels. Moreover, complete absence of WIF-1 mRNA expression was observed in four cell lines, whereas treatment with demethylating agent, 5-aza-2'-deoxycytidine, restored WIF-1 expression. Our results suggested that the WIF-1 gene is frequently silenced in astrocytoma by aberrant promoter methylation. This may be an important mechanism in astrocytoma carcinogenesis.
Insights
Wnt inhibitory factor-1 (WIF-1) gene silencing by promoter methylation is frequent in astrocytomas, leading to Wnt pathway activation and tumor development. This epigenetic silencing contributes to astrocytoma progression.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Wnt inhibitory factor-1 (WIF-1) is a Wnt antagonist and tumor suppressor.
- Aberrant Wnt signaling, driven by WIF-1 promoter hypermethylation and low expression, contributes to human tumor development.
- Understanding WIF-1's role in astrocytoma is crucial for targeted therapies.
Purpose of the Study:
- To investigate the expression and methylation status of the WIF-1 gene in astrocytoma.
- To determine the association between WIF-1 alterations and astrocytoma pathological grade.
- To explore the potential of WIF-1 re-expression via demethylation in glioblastoma cell lines.
Main Methods:
- RT-PCR and immunohistochemistry were used to assess WIF-1 mRNA and protein expression.
- Methylation-specific PCR analyzed WIF-1 gene promoter methylation.
- Glioblastoma cell lines were treated with a demethylating agent (5-aza-2'-deoxycytidine).
Main Results:
- Significant downregulation of WIF-1 mRNA and protein was observed in astrocytoma tissues compared to normal brain tissues.
- WIF-1 downregulation correlated significantly with higher astrocytoma pathological grades.
- Aberrant WIF-1 promoter methylation was detected in 54.29% of astrocytoma samples, correlating with reduced WIF-1 expression.
- Demethylating agent treatment restored WIF-1 expression in glioblastoma cell lines with silenced WIF-1.
Conclusions:
- The WIF-1 gene is frequently silenced in astrocytomas through aberrant promoter methylation.
- Epigenetic silencing of WIF-1 is a potential mechanism driving astrocytoma carcinogenesis.
- Targeting WIF-1 methylation could offer a therapeutic strategy for astrocytoma.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
05:45Quantitative Immunohistochemistry of the Cellular Microenvironment in Patient Glioblastoma Resections
Published on: July 31, 2017
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation